14 results
DEFM14A
SQZB
SQZ Biotechnologies Co
23 Jan 24
Proxy related to merger
4:31pm
with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed federal … and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare
PREM14A
SQZB
SQZ Biotechnologies Co
12 Jan 24
Preliminary proxy related to merger
8:57am
interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries … and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription
10-K
2020 FY
SQZB
SQZ Biotechnologies Co
18 Mar 21
Annual report
6:31am
interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional … inquiries and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost
424B4
SQZB
SQZ Biotechnologies Co
12 Feb 21
Prospectus supplement with pricing info
5:10pm
to drug pricing, reduce the cost of prescription drugs under Medicare, and review the relationship between pricing and manufacturer patient programs. We … States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed
DRS
719gv asz
1 Feb 21
Draft registration statement
12:00am
10-Q
ae3i4xxb1ra7g3w6avu
10 Dec 20
Quarterly report
4:46pm
424B4
tvkc4 vk9k
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
wq270svn1xre262
9 Oct 20
IPO registration
4:59pm
DRS/A
2bjwq9vjgjgjmqqtn
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
fp595
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
r542jwoxk 5q6ppqr
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next